Search

everythinglearnresearchcommunity

for

Search:↓

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Topical JAK inhibitors may help treat some skin conditions but need more research.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Finasteride effectively treats BPH and hair loss but may cause sexual side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.